A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients ...

Scientists at UNIGE have created an artificial intelligence method that can diagnose colorectal cancer by analyzing the gut ...

Colorectal cancer remains a leading cause of cancer death, with incidence rising among older adults. One of the most pressing ...

Be Aware of Symptoms: Pay attention to your body and any persistent changes. Common symptoms of colorectal cancer can include ...

Research highlights aspirin’s potential in lowering tumor return by 50% in patients with specific genetic mutations - Anadolu ...

Craig Melvin, Lindsay Czarniak, Dylan Dreyer and Willie Geist join TODAY to discuss the Bottoms Up Invitational, an event ...

ADG126 is a novel anti–CTLA-4 agent incorporating protease-cleavable masking technology that enables tumor-specific ...

Colorectal cancer is a complex disease. Understanding its fundamental aspects can empower you to have more informed and productive conversations with your oncologist.

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

The Greek Australian president of GESA Professor Alex Boussioutas, talks to Neos Kosmos about risk factors behind the growing rates of CRC in young ages, with the Australia experiencing some of the hi ...

A groundbreaking study reveals that a daily low dose of aspirin can significantly reduce the risk of colorectal cancer recurrence by approximately 55% in patients with specific PI3K pathway mutations.